Anika Therapeutics, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic · United States

Last price 20.95 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 280.37M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Anika Therapeutics, Inc., a joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally. The company offers osteoarthritis (OA) pain management products and services, such as Monovisc and Orthovisc, which are single- and multi-injection, HA viscosupplement products indicated for pain relief from OA conditions, as well as Cingal, a non-opioid, single-injection OA pain management product; regenerative solutions, including an HA-based scaffold with bone and tendon fixation components and ...